Purpose and Award
Helping those in the epilepsy community achieve their goals.
Outstanding accomplishments deserve recognition. UCB is celebrating 17 years of awarding academic scholarships to people living with epilepsy, their family members, and caregivers. The UCB Family Epilepsy Scholarship Program winners are an inspiring group of dedicated, resilient, and well-rounded individuals that have been impacted by epilepsy. They are a diverse group of patients, family members, and caregivers who demonstrate academic ambition and personal achievement, who also serve as positive role models for others.
In 2022, UCB will award 33 one-time scholarships to people living with epilepsy, their family members, and caregivers who are pursuing higher education. Thirty scholarships of up to $5,000 each will be awarded to outstanding applicants who demonstrate academic and personal achievement. In addition, two Epilepsy Leader Scholarships and one Joe D'Souza Memorial Scholarship of up to $10,000 each will be awarded to outstanding applicants.
The Epilepsy Leader Scholarships were created in 2016 in memory of Dr. Jack Pellock and Dr. Sandy Helmers, two prominent figures in the epilepsy community who passed away in 2016. The recipients will demonstrate academic and personal achievement and will also exemplify some of the qualities that Drs. Helmers and Pellock were best known for, including a desire to advocate for and serve others, an interest in positively contributing to the epilepsy community, and a persevering spirit.
The Joe D'Souza Memorial Scholarship was created in 2019 in memory of UCB's beloved global medical director and is awarded annually to the single applicant who most exemplifies Dr. D'Souza's spirit. Dr. D'Souza was recognized around the world for his commitment to those who suffer from epilepsy disorders and his work at the forefront of new epilepsy treatment. In addition to his undisputed achievements in antiepileptic drug development, he excelled in honesty, integrity, and genuine concern for the well-being of his colleagues and the epilepsy community.